NonCommunicable Disease Epidemiology Prevention Control Ahmed Mandil Hafsa
Non-Communicable Disease: Epidemiology, Prevention & Control Ahmed Mandil, Hafsa Raheel Dept of Family & Community Medicine KSU College of Medicine
Objectives n By the end of the session students should be able to; n n n Appreciate the burden of NCDs globally, regionally, and in the Kingdom of Saudi Arabia Enlist the risk factors for NCDs Understand the concept and application of primary, secondary, and tertiary prevention with regard to NCDs 2/21/2021 NCD Epi 2
Definitions (I) n n Chronic health-related state: a state which lasts for a long time, usually more than 3 months Chronic exposure: prolonged (long term), usually of low intensity. Chronic diseases: those diseases that have uncertain etiology, multiple risk factors, a prolonged course, do not resolve spontaneously, and for which a complete cure is rarely achieved. Non-communicable diseases (NCD): a miscellaneous group of health-related conditions, usually not communicated through infective pathogens, and may cause impairment, disability, handicap or even premature death. 2/21/2021 NCD Epi 3
Defintions (II) n n n Risk factor: an aspect of personal behavior / life-style, an environmental exposure, an inborn / inherited characteristic, which on the basis of epidemiologic evidence, is known to be associated with health-related condition(s) considered important to prevent. Modifiable risk factor: a determinant that can be modified by intervention, thereby reducing the probability of occurrence of disease or other specified outcomes. Latent period: delay between exposure to a disease-causing agent and the appearance of manifestations of the disease. E. g. after exposure to ionizing radiation, there is a latent period of 5 years, on the average, before development of leukemia, and > 20 years before development of certain other malignancies. 2/21/2021 NCD Epi 4
Definitions (III): Exceptional NCD n n n Some NCD were recently proven to be of infectious origin, e. g. peptic ulcer (Helicobacter pylori), liver carcinoma (HCV), cancer cervix (Human Papilloma Virus), leukemia (oncogenic viruses), etc. The term chronic may not apply to conditions as: angina pectoris, Acute Myocardial Infarction (AMI), anxiety, acute depression Some infectious diseases are chronic: e. g. T. B. , HIV / AIDS 2/21/2021 NCD Epi 5
NCD Examples (I) n n n Congenital anomalies Malnutrition (pediatric, geriatric) Endocrinal / metabolic disorders (e. g. diabetes, gout) Cardiovascular diseases (e. g. hypertension; atherosclerosis; ischemic heart disease [IHD]: angina, myocardial infarction). Locomotor system problems: e. g. arthritis (acute, chronic) Chronic respiratory conditions (e. g. bronchial asthma) 2/21/2021 NCD Epi 6
NCD Examples (II) n n n Occupational-related conditions (e. g. pneumoconiosis) Neoplasms (benign / malignant; childhood / adult) Injuries (intentional / non-intentional) Sensory loss (e. g. deafness, blindness) Diseases of senescence (degenerative diseases) Psychiatric disorders (neuroses, psychoses) 2/21/2021 NCD Epi 7
MISCONCEPTIONS 2/21/2021 NCD Epi 8
Reality: chronic diseases are concentrated among the poor 2/21/2021 NCD Epi 9
Reality: almost half in people under age 70 2/21/2021 NCD Epi 10
Reality: chronic diseases affect men and women almost equally 2/21/2021 NCD Epi 11
Reality: 80% of premature heart disease, stroke and type 2 diabetes is preventable, 40% of cancer is preventable 2/21/2021 NCD Epi 12
Reality: inexpensive and cost-effective interventions exist 2/21/2021 NCD Epi 13
MAGNITUDE OF THE PROBLEM 2/21/2021 NCD Epi 14
Magnitude of the Problem (I) • • • NCD are considered the leading causes of death and disability on a global scale, (for at least the last two decades of the 20 th century). Disease rates (morbidity and mortality) from these conditions are accelerating globally, advancing across regions and social classes Special burden in less developed nations. 2/21/2021 NCD Epi 15
Magnitude of the Problem (II) Among the many NCDs that contribute importantly to the global burden of disease, disability and death, cardiovascular disease (CVD), cancer, diabetes and chronic respiratory diseases are four of the most prominent. These four conditions are linked by common lifestyle determinants such as imbalanced diet, physical inactivity and tobacco consumption. They together contribute to 50% of global mortality. NCD are expected to account for an increasing share of disease burden, rising globally from 43% in 1998 to 73% by 2020. The expected increase is likely to be particularly rapid in less developed nations. 2/21/2021 NCD Epi 16
The Regional Situation § § The WHO Region for the Eastern Mediterranean, NCD - 52% of all deaths and 47% of the disease burden in EMR during the year 2005 This burden is likely to rise to 60% in the year 2020 2/21/2021 NCD Epi 17
4 Chronic Diseases result in 52 percent of deaths EMR Adult Population Cardiovascular 2/21/2021 Chronic Respiratory Disease Type 2 Diabetes NCD Epi Cancer 18
RISK FACTORS 2/21/2021 NCD Epi 19
NCD Causal Pathway 2/21/2021 NCD Epi 20
Risk Factors (I) n n n Aging of the population Use of motor vehicles (automobiles) Life-style changes n Poor / unbalanced / unhealthy nutrition n Tobacco consumption / addiction n Physical inactivity n Harmful use of alcohol consumption Obesity Other social and behavioral factors. 2/21/2021 NCD Epi 21
Risk factors (II) n Modifiable n n n n Cigarette smoking High Blood pressure Elevated serum Cholesterol Diabetes Life style changes (dietary patterns, physical activity) Stress factors Alcohol abuse 2/21/2021 n Non-Modifiable n n n NCD Epi Age Sex Family Hx Genetic factors Personality? Race 22
Risk factors (III): EMR n n n Tobacco use Hypertension Diabetes Overweight-obesity Dyslipidemia Physical Inactivity 2/21/2021 16 -65% 12 -35% 7 -25% 40 -70% 30 -70% 80 -90% NCD Epi 23
Sources of NCD Data n n n n Mortality statistics Hospital records (especially discharge) Disease registries (e. g. cancer / diabetes / hypertension registries) Interview surveys Occupational medical records Sickness and disability insurance statistics Drugs' dispensing statistics (prescribed, overthe-counter) 2/21/2021 NCD Epi 24
PREVENTION & CONTROL 2/21/2021 NCD Epi 25
NCD Prevention and control (I) Goals: n To reduce disease incidence n To prevent / delay onset of disability n To alleviate severity of disease n To prolong the individuals’ life (Inshaa-Allah) 2/21/2021 NCD Epi 26
NCD Prevention and control (II) n n n Important issues: One of the most important objectives of NCD control is the change of the public's perception of NCD from one of "inevitability" to that of "preventability". NCD control is based on avoidance of the most important risk factors (e. g. tobacco addiction, physical inactivity, poor nutrition), all of which are behavioral factors, often difficult to change. Healthy behaviors should be promoted early on in life through comprehensive school health education and efforts to change behavior in children and young people. 2/21/2021 NCD Epi 27
NCD Prevention and control (III) n n n Primary prevention n Population Strategy n High Risk strategy Secondary prevention Tertiary prevention 2/21/2021 NCD Epi 28
Population strategy n n n Health promotion & education Behavioral changes: balanced healthy diet, tobacco control, physical activity, weight reduction, especially children & adolescents Blood pressure control Self care Stress management 2/21/2021 NCD Epi 29
High Risk approach n n Identify high risk people and families, e. g. those with family history with an NCD (e. g. DM, hypertension); high serum cholesterol, etc Providing specific advice: helping them to exercise, reduce weight, diet control, etc 2/21/2021 NCD Epi 30
NCD Prevention and control: (III) Primary prevention n Directed at susceptible persons, before they develop a certain NCD, thus aims at reducing incidence. Needs establishment of risk factors, beforehand (community-specific). Examples: tobacco prevention programs, promotion of physical activity, dietary recommendations (for balanced diets suitable for age, gender, physical activities, growth & development, weather, community). 2/21/2021 NCD Epi 31
NCD Prevention and control: (IV): Secondary prevention n Directed at asymptomatic individuals, but have developed biological changes resulting from the disease, thus aims at reducing prevalence. Goal: early detection, management, avoiding / reducing undesirable consequences / complications. Examples: screening programs (e. g. for diabetes, hypertension, cancer), recommended when: natural history permits early detection, available screening tests for early detection, acceptable to the population at risk; effective management regimens 2/21/2021 NCD Epi 32
NCD Prevention and control: (V): Tertiary prevention n Tertiary prevention: Directed at preventing disability in people who have symptomatic disease, thus aims at trying to improve quality of life. Goal: prevention of progression of a disease and its complications; provision of rehabilitation. Examples: screening for / management of diabetic complications (e. g. retinopathy); orthopedic prosthesis (e. g. for fracture-hip); physiotherapy (e. g. for cardiovascular stroke / paralysis / sports injuries’ victims) 2/21/2021 NCD Epi 33
References 1 1. 2. 3. Last J. A dictionary of epidemiology. 5 th Edition. Oxford, New York, Toronto: Oxford University Press, 2008. Remington PL, Brownson RC, Wegner MV. Chronic disease epidemiology and control. 3 rd Edition. Washington, D. C. : American Public Health Association, 2010. WHO. 2008 -2013 Action Plan for the Global Strategy for the Prevention and Control of Non-communicable Diseases. Geneva: WHO, 2008 2/21/2021 NCD Epi 34
References 2 4. 5. 6. Fadhil I. Diabetes and other noncommunicable diseases: An Eastern Mediterranean Perspective. WHO, 2009 Kuh D, Ben Shlomo Y. A life course approach to chronic disease epidemiology. Oxford, New York, Toronto: Oxford University Press, 1997. Newcomer RJ, Benjamin AE. Indicators of chronic health conditions. Baltimore, London: The Johns Hopkins University Press, 1997. 2/21/2021 NCD Epi 35
- Slides: 35